Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis

基因间风险变异rs56258221通过miR4464-BACH2相互作用影响原发性硬化性胆管炎中初始CD4+ T细胞的命运

阅读:6
作者:Tobias Poch ,Jonas Bahn ,Christian Casar ,Jenny Krause ,Ioannis Evangelakos ,Hilla Gilladi ,Lilly K Kunzmann ,Alena Laschtowitz ,Nicola Iuso ,Anne-Marie Schäfer ,Laura A Liebig ,Silja Steinmann ,Marcial Sebode ,Trine Folseraas ,Lise K Engesæter ,Tom H Karlsen ,Andre Franke ,Norbert Hubner ,Christian Schlein ,Eithan Galun ,Samuel Huber ,Ansgar W Lohse ,Nicola Gagliani ,Dorothee Schwinge ,Christoph Schramm

Abstract

Primary sclerosing cholangitis (PSC) is an immune-mediated liver disease of unknown pathogenesis, with a high risk to develop cirrhosis and malignancies. Functional dysregulation of T cells and association with genetic polymorphisms in T cell-related genes were previously reported for PSC. Here, we genotyped a representative PSC cohort for several disease-associated risk loci and identified rs56258221 (BACH2/MIR4464) to correlate with not only the peripheral blood T cell immunophenotype but also the functional capacities of naive CD4+ T (CD4+ TN) cells in people with PSC. Mechanistically, rs56258221 leads to an increased expression of miR4464, in turn causing attenuated translation of BACH2, a major gatekeeper of T cell quiescence. Thereby, the fate of CD4+ TN is skewed toward polarization into pro-inflammatory subsets. Clinically, people with PSC carrying rs56258221 show signs of accelerated disease progression. The data presented here highlight the importance of assigning functional outcomes to disease-associated genetic polymorphisms as potential drivers of diseases.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。